STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy
With two approved Alzheimer’s antibody therapies already on the market, is there room for more such treatments designed to clear out the sticky amyloid plaques associated with the disease? Well, investors at Fairmount, Venrock, Wellington Management, and TCGX believe so. The...
🔗 Read more: https://www.statnews.com/2026/02/18/korsana-biosciences-alzheimers-brain-shuttles/?utm_campaign=rss
#News #Medicine #Business #Biology #Biotech #Tech #Science
Edited
www.statnews.com
STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy
With two approved Alzheimer’s antibody therapies already on the market, is there room for more such treatments designed to clear out the sticky amyloid plaques associated with the disease? Well, investors at Fairmount, Venrock, Wellington Management, and TCGX believe so. They and other firms have...
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!